OVERVIEW
The pursuit of health sector efficiency and value for money are central dimensions of health care performance in GCC countries. Pharmacoeconomics and healthcare technologies assessment (HTA), are key capabilities to support decision making and provide valuable insights to management and policy making in healthcare.
The event is a strategic meeting, gathering key stakeholders to explore key issues and latest advances in the areas of Pharmacoeconomics, value-based Healthcare and evidence-based medication, HTA and outcomes to achieve regulatory adherence, analyse costs and benefits, and improve access to lifesaving medicines and ensure affordability of essential medicines.
- Regulatory authorities
- Pharmacoeconomists
- Health Economists
- Health Technology Assessment Specialists
- Payers
- Healthcare providers
- Pharma industry
- Pharmacists and more
Who Should Attend
KEY BENEFITS OF ATTENDING
- Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
- Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
- Understanding the principles of outcome based healthcare and evidence based medication
- Reviewing pharmacoeconomics and outcomes research strategies
- Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making
Summit Chairman
Ahmed Al Jedai
Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA
Scientific Committee Chair
Hajer Al-Mudaiheem
Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA
Summit Packages
2-Days Summit
Hospital and Community Pharmacists
Pharmaceutical Companies and Solution Providers
for Group Registration
Please contact: +971 4 361 9616
Scientific Committee Members
Ahmed Al Jedai
Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA
Amin Elshamy
Consultant of Wellbeing and SDGs, Ministry of Health and Prevention, UAE
Anas Hamad
PhD, MSc, DMS, BPharm, RPh, Director of Pharmacy Department, National Center for Cancer Care & Research NCCCR, Qatar
Hajer Al-Mudaiheem
Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA
Khuloud Bin Rafeea
Director of Drugs and Medical Products, Department of Health, Abu Dhabi, Abu Dhabi, UAE
Maryam Alowayesh
PhD, MSc, Assistant Professor, School of Pharmacy, College of Pharmacy – Kuwait University, President, ISPOR Kuwait Chapter, Kuwait
Mouna Jameleddine
Director, Health Technology Assessment Department, National
Authority for Assessment and Accreditation in Healthcare (INEAS), Tunisia
Sara Al Dallal
MBBS, MSc, President, Emirates Health
Economics Society, Emirates Medical Association; Senior Health Service Specialist, Dubai Health Authority, UAE
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
